uracil has been researched along with Cancer of Head in 51 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with stage III, IVA, or IVB LAHNSCC were enrolled in this study to evaluate the efficacy of S-1 compared with UFT as adjuvant chemotherapy after curative CRT in the ACTS-HNC study." | 2.87 | Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study. ( Beppu, T; Fujii, M; Hanamure, Y; Hasegawa, Y; Higaki, Y; Iwae, S; Kawabata, K; Kohno, N; Kubota, A; Nagahara, K; Nakatani, E; Nakatani, H; Taguchi, T; Takemura, H; Terada, T; Teramukai, S; Tomita, K; Tsukahara, K; Yoshino, K, 2018) |
| "Irinotecan was supplied at doses of 40, 50, 60, and 70 mg/m(2) by using a standard 3+3 design." | 2.82 | Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study. ( Chang, PM; Chen, SC; Yang, MH, 2016) |
| "Deleterious oral mucositis (OM) develops during radiotherapy (RT) or chemoradiotherapy for head-and-neck cancer (HNC) patients." | 2.77 | Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. ( Chung, YL; Jen, YM; Lin, YH; Wang, LW; Yen, SH, 2012) |
| "To test the efficacy and safety of pharmacokinetic modulating chemotherapy combined with cisplatin (PMC-cisplatin) as induction chemotherapy (ICT) before definitive treatment in patients with respectable locally advanced head and neck squamous cell carcinoma (HNSCC)." | 2.73 | Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. ( Chang, PM; Chang, SY; Chen, PM; Chu, PY; Huang, JL; Tai, SK; Tsai, TL; Wang, LW; Wang, YF; Yang, MH, 2008) |
| " In total, 79 courses were administered with a median of 3 (range 1-6)." | 2.72 | UFT in combination with oxaliplatin: clinical phase I study in patients with advanced or metastatic solid tumors. ( Abad, A; Aranda, E; Carrato, A; Díaz-Rubio, E; Gallego, J; Gómez, A; López, E; Manzano, JL; Sastre, J, 2006) |
| "A trend of better distant control in head and neck cancer patients with post-operative adjuvant oral chemotherapy was observed." | 2.70 | Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma. ( Ho, CM; Ho, WK; Lam, P; Wei, WI; Yuen, AP, 2001) |
| "Eniluracil is a novel DPD-inactivator designed to prolong the half-life of 5-FU and provide sustained plasma concentrations of 5-FU with oral dosing." | 2.69 | Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. ( Brockstein, B; Dolan, ME; Haraf, DJ; Humerickhouse, RA; Kies, M; Ratain, MJ; Stenson, K; Sulzen, L; Vokes, EE, 1999) |
| "For locally unresectable recurrent squamous cell carcinoma of the head and neck, we investigated two salvage chemotherapy regimens as second-line chemotherapy." | 2.69 | Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck. ( Kawaida, M; Kitahara, S; Kohno, N; Ohmuma, T, 1999) |
| " Trials of new combinations are warranted to take advantage of the pharmacokinetic properties and oral bioavailability of UFT and leucovorin." | 2.68 | Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast. ( Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P, 1997) |
| " The administration of the conventional dose of S-1 including dihydropyrimidine dehydrogenase (DPD), an metabolic inhibitor of 5-FU, results in exceeding the critical plasma concentration of 5-FU, and the long-term administration with high plasma concentration of 5-FU is considered to show clinical effectiveness in head and neck cancer." | 2.43 | [Clinical efficacy of administration with S-1 alone for head and neck carcinoma]. ( Horiuchi, C; Ishitoya, J; Katori, H; Matsuda, H; Mikami, Y; Taguchi, T; Toth, G; Tsukuda, M; Yoshida, T, 2006) |
| "Comparative clinical studies of head and neck cancer have not provided good evidence, with the exception of an RCT of adjuvant chemotherapy with UFT, in the past." | 2.41 | [Comparative clinical studies for head and neck cancer in Japan]. ( Fujii, M, 2002) |
| "The common clinical presentations of head and neck cancer include early (stage I or II) disease, locally or regionally advanced (stage III or IV, M0) disease, and recurrent or metastatic disease (< 5% of patients)." | 2.40 | Oral 5-FU alternatives for the treatment of head and neck cancer. ( Brockstein, BE; Haraf, DJ; Humerickhouse, R; Vokes, EE, 1998) |
| "5-Fluorouracil (5-FU) is a mainstay for treating various solid tumours in adults, including digestive and head and neck cancers." | 1.37 | 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases. ( Ciccolini, J; Cordier, PY; Lacarelle, B; Mercier, C; Nau, A; Oliver, M; Peytel, E, 2011) |
| "Thirty-one patients with head and neck cancer were administered pretreatment induction chemotherapy (so-called neo-adjuvant chemotherapy) consisting of a UFT and ADM combination." | 1.27 | [Neo-adjuvant chemotherapy with UFT and adriamycin in head and neck cancer]. ( Hyo, N; Imura, S; Kishimoto, M; Kumoi, T; Ogasawara, H; Toda, K, 1987) |
| "A Phase II study of UFT for head and neck cancer was conducted in 10 institutions." | 1.27 | [Phase II study of UFT for head and neck cancer]. ( Fujii, M; Hirokawa, T; Horiuchi, M; Inuyama, Y; Kaneko, S; Miyake, H; Ooyama, W; Takeda, C; Tanaka, J; Uchida, M, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (15.69) | 18.7374 |
| 1990's | 21 (41.18) | 18.2507 |
| 2000's | 17 (33.33) | 29.6817 |
| 2010's | 5 (9.80) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishio-Nagai, M | 1 |
| Suzuki, S | 1 |
| Yoshikawa, K | 1 |
| Ueda, R | 1 |
| Kazaoka, Y | 1 |
| Kubota, A | 3 |
| Nakatani, E | 1 |
| Tsukahara, K | 1 |
| Hasegawa, Y | 1 |
| Takemura, H | 1 |
| Terada, T | 1 |
| Taguchi, T | 4 |
| Nagahara, K | 1 |
| Nakatani, H | 1 |
| Yoshino, K | 1 |
| Higaki, Y | 1 |
| Iwae, S | 1 |
| Beppu, T | 1 |
| Hanamure, Y | 1 |
| Tomita, K | 1 |
| Kohno, N | 4 |
| Kawabata, K | 1 |
| Teramukai, S | 1 |
| Fujii, M | 8 |
| Chen, SC | 1 |
| Chang, PM | 2 |
| Yang, MH | 2 |
| Rivera, F | 3 |
| Eugenia Vega-Villegas, M | 1 |
| López, C | 1 |
| Francisca López-Brea, M | 1 |
| Rubio, A | 3 |
| Del Valle, A | 3 |
| García-Reija, F | 2 |
| García-Montesinos, B | 2 |
| Rodríguez-Iglesias, J | 2 |
| Hinojo, C | 1 |
| Márquez, R | 1 |
| Angel Alonso-Bermejo, M | 1 |
| Salcedo, M | 1 |
| Blanco, Y | 1 |
| Vega, N | 1 |
| López-Tarruella, S | 1 |
| Sanz-Ortiz, J | 3 |
| Cordier, PY | 1 |
| Nau, A | 1 |
| Ciccolini, J | 1 |
| Oliver, M | 1 |
| Mercier, C | 1 |
| Lacarelle, B | 1 |
| Peytel, E | 1 |
| Yen, SH | 1 |
| Wang, LW | 2 |
| Lin, YH | 1 |
| Jen, YM | 1 |
| Chung, YL | 1 |
| Emura, T | 1 |
| Nakagawa, F | 1 |
| Fujioka, A | 1 |
| Ohshimo, H | 1 |
| Kitazato, K | 1 |
| Furukawa, M | 1 |
| Kawano, T | 1 |
| Komatsu, M | 1 |
| Sastre, J | 1 |
| Aranda, E | 1 |
| Abad, A | 1 |
| Gallego, J | 1 |
| Manzano, JL | 1 |
| Gómez, A | 1 |
| Carrato, A | 1 |
| López, E | 1 |
| Díaz-Rubio, E | 2 |
| Tsukuda, M | 6 |
| Ishitoya, J | 1 |
| Mikami, Y | 1 |
| Matsuda, H | 1 |
| Katori, H | 2 |
| Horiuchi, C | 1 |
| Yoshida, T | 1 |
| Toth, G | 1 |
| Vega-Villegas, ME | 2 |
| López-Brea, MF | 1 |
| García-Castaño, A | 1 |
| de Juan, A | 1 |
| Ramos, FJ | 1 |
| Collado, A | 1 |
| Galdós, P | 2 |
| Rama, J | 2 |
| Mayorga, M | 2 |
| López-Brea, M | 1 |
| Isla, D | 1 |
| Mayordomo, J | 1 |
| Saiz-Bustillo, R | 1 |
| Chen, PM | 1 |
| Chu, PY | 1 |
| Tai, SK | 1 |
| Tsai, TL | 1 |
| Huang, JL | 1 |
| Wang, YF | 1 |
| Chang, SY | 1 |
| Kusama, M | 1 |
| Utsunomiya, Y | 1 |
| Ono, T | 1 |
| Nagura, H | 1 |
| Enomoto, S | 1 |
| Ogasawara, H | 3 |
| Kaneko, S | 3 |
| Komiyama, S | 2 |
| Horiuchi, M | 4 |
| Inuyama, Y | 6 |
| Uemura, T | 1 |
| Uchida, M | 2 |
| Kamata, S | 1 |
| Okuda, M | 1 |
| Homma, A | 1 |
| Iizuka, K | 1 |
| Nakamaru, Y | 1 |
| Yonekawa, H | 1 |
| Suzuki, K | 1 |
| Itaya, S | 1 |
| Tsuge, I | 1 |
| Matsuda, T | 1 |
| Motai, H | 1 |
| Kobayashi, T | 1 |
| Shimada, J | 1 |
| Baba, S | 1 |
| Fleming, RA | 2 |
| Milano, GA | 1 |
| Gaspard, MH | 1 |
| Bargnoux, PJ | 1 |
| Thyss, A | 2 |
| Plagne, R | 1 |
| Renée, N | 2 |
| Schneider, M | 2 |
| Demard, F | 2 |
| Somekawa, Y | 1 |
| Asano, K | 1 |
| Taira, A | 1 |
| Imai, R | 1 |
| Fukuda, S | 2 |
| Tanaka, K | 1 |
| Kawaura, M | 1 |
| Kawasaki, K | 1 |
| Ohno, Y | 1 |
| Tokumaru, Y | 1 |
| Imanishi, Y | 1 |
| Kanke, M | 1 |
| Feliu, J | 1 |
| González Barón, M | 1 |
| Zamora, P | 1 |
| Garcia Alfonso, P | 1 |
| Garcia Girón, C | 1 |
| Blanco, E | 1 |
| Belón, J | 1 |
| Garrido, P | 1 |
| Jara, C | 1 |
| Ruiz, A | 1 |
| Vincent, JM | 1 |
| Espinosa, E | 1 |
| Furuta, Y | 1 |
| Yagi, K | 1 |
| Nagahashi, T | 1 |
| Chida, E | 1 |
| Shirato, H | 2 |
| Kanzaki, J | 1 |
| Colevas, AD | 2 |
| González-Larriba, JL | 1 |
| Garcia Carbonero, I | 1 |
| Sastre Valera, J | 1 |
| Perez Segura, P | 1 |
| Vokes, EE | 2 |
| Brockstein, BE | 1 |
| Humerickhouse, R | 1 |
| Haraf, DJ | 2 |
| Humerickhouse, RA | 1 |
| Dolan, ME | 1 |
| Brockstein, B | 1 |
| Stenson, K | 1 |
| Kies, M | 1 |
| Sulzen, L | 1 |
| Ratain, MJ | 1 |
| Kawakami, M | 1 |
| Ikai, S | 1 |
| Hashimoto, K | 1 |
| Ito, T | 1 |
| Takenaka, H | 1 |
| Nishino, H | 1 |
| Abe, K | 1 |
| Ishikawa, K | 1 |
| Kanazawa, T | 1 |
| Tanaka, H | 1 |
| Miyata, M | 1 |
| Kitamura, K | 1 |
| Morita, M | 1 |
| Kitahara, S | 1 |
| Kawaida, M | 1 |
| Ohmuma, T | 1 |
| Nishimura, G | 1 |
| Yanoma, S | 1 |
| Mizuno, H | 1 |
| Satake, K | 1 |
| Ikeda, Y | 1 |
| Mercke, C | 1 |
| Lewis, NL | 1 |
| Meropol, NJ | 1 |
| Amrein, PC | 1 |
| Gomolin, H | 1 |
| Barton, JJ | 1 |
| Read, RR | 1 |
| Adak, S | 1 |
| Benner, S | 1 |
| Costello, R | 1 |
| Posner, MR | 1 |
| Knowling, M | 1 |
| Browman, G | 1 |
| Siu, L | 1 |
| Khoo, K | 1 |
| Cooke, A | 1 |
| Tannock, I | 1 |
| Klaassen, D | 1 |
| Cripps, C | 1 |
| Goss, G | 1 |
| Matthews, S | 1 |
| Clarke, R | 1 |
| Seymour, L | 1 |
| Lam, P | 1 |
| Yuen, AP | 1 |
| Ho, CM | 1 |
| Ho, WK | 1 |
| Wei, WI | 1 |
| Katayama, A | 1 |
| Nonaka, S | 1 |
| Bandoh, N | 1 |
| Imada, M | 1 |
| Hayashi, T | 1 |
| Harabuchi, Y | 1 |
| Nakashima, T | 1 |
| Miyagi, M | 1 |
| Kusumoto, T | 1 |
| Milano, G | 1 |
| Etienne, MC | 1 |
| Ohyama, M | 1 |
| Matsumura, M | 1 |
| Katsuta, K | 1 |
| Nobori, T | 1 |
| Matsuyama, H | 1 |
| Fukami, K | 1 |
| Kiyota, R | 1 |
| Yano, H | 1 |
| Shima, T | 1 |
| Ogawa, K | 1 |
| Sugita, M | 1 |
| Miyake, H | 3 |
| Takahashi, H | 1 |
| Yao, K | 1 |
| Sawaki, S | 1 |
| Takeyama, I | 1 |
| Kikuchihara, M | 1 |
| Kubota, T | 1 |
| Tsuji, H | 2 |
| Tsujii, H | 2 |
| Kamada, T | 2 |
| Takamura, A | 2 |
| Matsuoka, Y | 2 |
| Irie, G | 2 |
| Usubuchi, H | 1 |
| Tanaka, J | 3 |
| Takaoka, T | 2 |
| Hosoda, H | 2 |
| Tachibana, M | 1 |
| Yasuda, N | 1 |
| Yoshimatsu, M | 1 |
| Nishimura, H | 1 |
| Mizukoshi, O | 1 |
| Toda, K | 1 |
| Kishimoto, M | 1 |
| Imura, S | 1 |
| Hyo, N | 1 |
| Kumoi, T | 1 |
| Takeda, C | 1 |
| Hirokawa, T | 1 |
| Ooyama, W | 1 |
| Saito, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase Ib/II Study of Ramucirumab (Cyramza®), Nal-IRI (ONIVYDE®) and Trifluridine/Tipiracil (Lonsurf®) in Second Line Metastatic Gastric Cancer (COOL Study).[NCT05927857] | Phase 1/Phase 2 | 45 participants (Anticipated) | Interventional | 2023-09-01 | Not yet recruiting | ||
| A Phase II Study of Maintenance Tegafur-uracil in Patients With Squamous Cell Carcinoma of Oral Cavity With Extracapsular Spreading of Lymph Nodes[NCT03121313] | Phase 2 | 68 participants (Anticipated) | Interventional | 2015-02-26 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for uracil and Cancer of Head
| Article | Year |
|---|---|
[Comparative clinical studies for head and neck cancer in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Com | 2002 |
[Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2006 |
[Head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Ci | 1996 |
The role of chemotherapy in the treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, | 1997 |
Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Che | 1997 |
Oral 5-FU alternatives for the treatment of head and neck cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 1998 |
Oral fluoropyrimidines in cancer treatment.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colo | 2000 |
22 trials available for uracil and Cancer of Head
| Article | Year |
|---|---|
Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemor | 2018 |
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; | 2016 |
Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Double-Blind Method; E | 2012 |
UFT in combination with oxaliplatin: clinical phase I study in patients with advanced or metastatic solid tumors.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, | 2006 |
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Car | 2007 |
Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; F | 2007 |
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Su | 2008 |
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2008 |
[A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 1994 |
[Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 1996 |
[Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squ | 1996 |
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carci | 1997 |
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous C | 1997 |
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combin | 1999 |
[Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carci | 1999 |
Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dr | 1999 |
UFT/leucovorin in advanced squamous cell carcinoma of the head and neck administered with radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Moda | 2000 |
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Antimetabolites, Antineoplastic; Antin | 2001 |
A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Canada | 2001 |
Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma.
Topics: Adjuvants, Immunologic; Adult; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; He | 2001 |
[Investigation of UFT and radiation combination therapy of head and neck cancer--mainly in laryngeal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1990 |
Clinical trials on UFT in the treatment of head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Tria | 1985 |
22 other studies available for uracil and Cancer of Head
| Article | Year |
|---|---|
Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Prolifera | 2017 |
Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 2008 |
5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases.
Topics: Aged; Antimetabolites, Antineoplastic; Brain; Dihydropyrimidine Dehydrogenase Deficiency; Electroenc | 2011 |
Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
Topics: Animals; Antineoplastic Agents; Cell Division; Drug Combinations; Head and Neck Neoplasms; Humans; M | 2004 |
[Nedaplatin for recurrent cancer of the head and neck].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2004 |
[Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fluorourac | 1983 |
[The effect of induction chemotherapy with CBDCA, 5-FU and UFT in head and neck cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Admini | 1994 |
[Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Head and Neck Neo | 1993 |
Dihydropyrimidine dehydrogenase activity in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Head and N | 1993 |
[Giant metastatic neck tumor responding to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1999 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy | 2000 |
[Evaluation of preoperative simultaneous radiochemotherapy combined with carboplatin and tegafur.uracil].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carbop | 2002 |
[Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 1992 |
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Head and N | 1992 |
[A comparative study of UFT enteric-coated granules with UFT capsules on the occurrence of side effects in patients with head and neck cancers--a special attention to the upper gastrointestinal tract disorders].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capsules; Diarrhea; | 1990 |
[Usage of urine FT levels for medication compliance in head and neck cancer with administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; | 1990 |
[Combined chemotherapy and radiotherapy in recurrent tumors of the head and neck region].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1987 |
Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, | 1989 |
[Preoperative chemotherapy for head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Fluorouracil; Head and Neck Ne | 1985 |
UFT for head and neck cancers: its tissue concentrations and effects on lymphocyte subpopulations.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modali | 1987 |
[Neo-adjuvant chemotherapy with UFT and adriamycin in head and neck cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Moda | 1987 |
[Phase II study of UFT for head and neck cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Head and Neck | 1985 |